Physician

Bradley Alan Switzer, MD

According to 2025 Medicare claims, Bradley Switzer, MD (NPI: 1184779969) practices hematology/oncology in the Worcester, MA market, with the plurality of this provider's patient population coming from Worcester, MA. This provider's primary affiliated billing organization is RELIANT MEDICAL GROUP, INC (NPI: 1720017528; TIN: 042472266) and primary practice location at 01606-2714. Switzer is affiliated with the Atrius Health, Inc. (ACO ID: A5088) and Reliant Medical Group, Inc. (ACO ID: D0218), participating under both the MSSP and REACH models.

Switzer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 453 traditional Medicare patients, billed 79,773 HCPCS/CPT codes, and received $1,236,741 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,362 prescription claims across 259 beneficiaries totaling $3,154,904 in drug costs, led by Revlimid (Lenalidomide). DME data shows 11 claims. Open Payments data shows 4 records totaling $19,529. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $54,295 to $1,236,741. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $513,449 to $3,154,904. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	305	729	$54,295
2016	386	1,031	$77,266
2017	345	919	$70,722
2018	289	5,265	$119,649
2019	293	3,924	$118,019
2020	295	3,698	$129,045
2021	407	57,946	$1,190,511
2022	512	88,621	$1,555,623
2023	480	83,171	$1,273,439
2024	453	79,773	$1,236,741

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	86	460	$513,449
2016	95	631	$742,068
2017	97	599	$765,402
2018	155	604	$547,926
2019	195	983	$1,224,708
2020	229	1,443	$2,452,030
2021	266	1,535	$2,969,562
2022	319	1,896	$3,624,127
2023	281	1,663	$3,037,348
2024	259	1,362	$3,154,904

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	82	$40,901
2016	N/R	56	$34,126
2017	N/R	100	$39,214
2018	N/R	26	$4,689
2019	N/R	N/R	N/R
2020	N/R	11	$210
2021	N/R	59	$5,001
2022	N/R	73	$2,406
2023	N/R	N/R	N/R
2024	N/R	11	$1,128

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	66	171	$138
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	102	198	$95
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	128	168	$61
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	113	169	$50
96375	Injection of additional new drug or substance into vein	80	279	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	31	861	$610,685
Calquence	Acalabrutinib Maleate	27	810	$325,254
Lenalidomide	Lenalidomide	20	560	$268,264
Tasigna	Nilotinib Hcl	11	308	$218,973
Kisqali	Ribociclib Succinate	12	336	$210,102

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	N/R	11	$1,128

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$58	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$19,471	Amgen Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bradley Alan Switzer, MD?

Tedicare shows public-source Medicare data for Bradley Alan Switzer, MD (NPI 1184779969), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bradley Alan Switzer, MD have ACO affiliation data?

Bradley Alan Switzer, MD is shown with ACO affiliation data for Atrius Health, Inc. (MSSP, ACO ID A5088) and Reliant Medical Group, Inc. (REACH, ACO ID D0218).

What billing organization is linked to Bradley Alan Switzer, MD?

Bradley Alan Switzer, MD is linked to RELIANT MEDICAL GROUP, INC (billing NPI 1720017528) in the available physician profile data.

Does Bradley Alan Switzer, MD have Open Payments data?

Bradley Alan Switzer, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.